ENSC - Ensysce Biosciences, Inc.
0.5471
0.008 1.499%
Share volume: 709,452
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.54
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-14-2024 | 11-12-2024 | 03-10-2025 | 05-13-2025 | 08-13-2025 | 11-14-2025 | |
| Total revenue | -1.248 M | 0.000 | 0.000 | 1.248 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Selling general and admin | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating income | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Ebit | -3.091 M | -1.955 M | 644.746 K | -2.328 M | -1.968 M | -1.751 M | -3.741 M | |
| Pretax income | -3.117 M | -1.968 M | 661.769 K | -3.564 M | -1.946 M | -1.734 M | -3.729 M | |
| -36.86% | -133.63% | -638.62% | -45.42% | -10.90% | 115.12% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.117 M | -1.968 M | 661.769 K | -3.564 M | -1.946 M | -1.734 M | -3.729 M | |
| 36.86% | 133.63% | -638.62% | 45.42% | 10.90% | -115.12% |